Torrent Pharma Q1 FY27 revenue climbs 55%; profit rises 3% amid JB Pharma costs
Torrent Pharma reported Q1 FY27 revenue of Rs 4,921 crore, up nearly 55% year on year, while EBITDA rose 61% to Rs 1,664 crore. Net profit increased 3% to Rs 566 crore after a Rs 21 crore one-time loss linked to the JB Pharma amalgamation. India revenue grew 19% to Rs 2,157 crore.
Torrent Pharma reported Q1 FY27 revenue growth of nearly 55% and EBITDA growth of 61%, while net profit rose 3% amid JB Pharma amalgamation costs. India revenue grew 19% to Rs 2,157 crore, outperforming the Indian Pharmaceutical Market’s 12% growth.
Why this matters
No related recent signals were provided. Q1 FY27 shows Torrent Pharma combining strong revenue and EBITDA growth with costs associated with the JB Pharma amalgamation.
Retail-company signals are accelerating, up 316075% QoQ.